Vyvanse 40 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DR26F00D5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,472
Award facts
- Contract value 100% obligated
- $5,472.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on November 4, 2025, for Vyvanse 40 mg capsules (100-count units) with a ceiling value of $5,472.45. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of $999,999,999.00 and runs through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's federal contracting demonstrates extensive experience fulfilling diverse medical supply needs through competitive awards with the DLA, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Vyvanse, a controlled substance commonly prescribed for attention deficit hyperactivity disorder, reflects the company's role in supplying essential pharmaceutical products to support Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F00D5?
SPE2DR26F00D5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F00D5 worth?
The government has obligated $5,472 on SPE2DR26F00D5.
Is contract SPE2DR26F00D5 an order under another contract?
Yes. SPE2DR26F00D5 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F00D5 competed?
The extent of competition for SPE2DR26F00D5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award